References
- Abraham MH, Cola JMR, Cornette-Muniz JE, Cain WS (2002): A model for odour thresholds. Chem Senses 27: 95-104 https://doi.org/10.1093/chemse/27.2.95
- Accelrys (2000): TSAR; Proprietary software (Ver. 3.3), User Guide., Oxford Molecular: Solutions for discovery Research. Oxford Molecular Ltd
- Bignetti E, Cavaggioni A, Pelosi P, Persaud KC, Sorbi RT, Tirinedelli R (1985): Purification and characterization of an odorant binding protein from cow nasal tissue. Eur J Biochem 149: 227-231 https://doi.org/10.1111/j.1432-1033.1985.tb08916.x
- Buck LB (2004): The search for odorant receptors. commentary. Cell. 116, 5117-5119
- Chen H, Li Q Yao X, Fan B, Yuan S, Pannaye A, Doucet JP (2003): 3D-QSAR and docking study of the binding mode of steroids to progesterone receptor in active site. QSAR Comb Asi 22: 604-613 https://doi.org/10.1002/qsar.200330820
- Dal Monte M, Centini M, Anselmi C, Pelosi P (1993): Binding of selected odorants to bovine and porcine odorant-binding proteins. Chem Sences 18: 713-721 https://doi.org/10.1093/chemse/18.6.713
- Hansch C, Leo A (1995): Exploring QSAR; Fundamentals and Applications in Chemistry and Biology. ACS Professional Reference Book, American Chemical Society, Washington, DC. pp 25-65
- Kansy M (1996): Molecular properties. In: Waterbeemed H (ed.). Structure-Property Correlations Drug Research. Academic Press, RG. Landers, Co., Austin. Ch.2
- Kitchen DB, Decomez H, Furr JR, Bajorath J (2004): Docking and scoring in virtual screening for drug discoverry: Methods and applications. Nat Rev Grug Discov 3:935-949 https://doi.org/10.1038/nrd1549
- Kubinyi H (1993): 3D-QSAR Drug Design, Theory, Methods and Applications, ESCOM. Leiden
- Pelosi P (1994): Odorant-binding proteins. Crit Rev Biochem Mol BioI 29:199-228 https://doi.org/10.3109/10409239409086801
- Pevsner J, Hou V, Snowman AM, Snyder SH (1990): Odorant-binding protein, charaterization of ligand binding. J BioI Chem 265: 6118-6125
- Rossiter KJ (1996): Structure-odor relationships. Chem Rev 96:3201-3240 https://doi.org/10.1021/cr950068a
- Shrestha NP, Edwards S, English PR, Robertson JF (2001): An evaluation boar pheromon spray to aid the stimulation and detection of estrus in small farms in Nepal. Asian-Aust J Anim Sci 14:697-700 https://doi.org/10.5713/ajas.2001.697
- Sung ND (2002): Development of new agrochemicals by quantitative structure-activity relationship (QSAR) methodlogy. II. The linear free energy relationship (LFER) and descriptors. Kor J Pesticide Sci 6:231-243
-
Sung ND, Kim CH, Jin DI, Park CS (2004): The search of pig pheromonal ordorants for biostimulation control system technologies: I. Ligand based molecular shape similarity of 5
$\alpha$ -androst-16-en-3-one analogous and their physico-chemical parameters. Reprod Dev Biol 28:45-52 - Sung ND, Park CS, Choi YS, Myung PK, (2005): The search of pig pheromonal ordorants for biostimulation control system technologies: II. Holographic QSAR model for binding affinities between ligand of volatile odorants molecules and porcine odorants binding protein (pOBP). Reprod Dev Biol 29:43-48
- Sung ND, Park CS, Hung HS, Seong MK, (2006a): The search of pig pheromonal ordorants for biostimulation control system technologies: III. Comparative molecular field analysis (CoMPA) on binding affinities between ligands of 2-(cyClohexyloxy)tetrahydrofurane derivatives and porcine odorants binding protein. Reprod Dev Biol 30:13-19
- Sung ND, Park CS, Jang SC, Choi KS (2006b): The search of pig pheromonal ordorants for biostimulation control system technologies: IV. Comparative molecular similarity indices analysis (CoMSIA) on binding affinities between ligands of 2-(cyclohexyloxy)tetrahydrofurane derivatives and porcine odorants binding protein. Reprod Dev Biol 30:169-174
- Topliss JG, Edwards RP (1979): Chance factors in studies of quantitative structure activity relationships. J Med Chem 22:1238-1244 https://doi.org/10.1021/jm00196a017
- Verloop A, Hoogenstrraten W, Tipker J (1976): Drug Design. In: Ariens EJ (ed.). Development and application of new steric substituent parameters in drug design. Academic Press, New York. Vo. 7, pp 165-207